Published: 16 February 2022
Author(s): Jun Chen, Mei Yu, Rui Zeng, Yimin Wang, Qiang Liu
Issue: June 2022

With the continuous development of cancer treatment, patients with cancer have dramatically improved, with several cancer populations experiencing a median survival well beyond 5 years.1 However, malignancy cancer has an innegligible impact on the cardiovascular system, not only the cancer itself, but also the adverse effects of treatments (drugs or radiation). Recently, increasing data have shown that cancer survivors have increased rates of major cardiovascular events, including cardiac arrest, with poorer outcomes.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.